McBroom & Associates’s Nucor NUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-28,045
Closed -$4.22M 37
2024
Q3
$4.22M Sell
28,045
-345
-1% -$51.9K 2.58% 18
2024
Q2
$4.49M Buy
28,390
+281
+1% +$48.8K 2.81% 16
2024
Q1
$5.56M Sell
28,109
-303
-1% -$55.4K 3.66% 16
2023
Q4
$4.94M Sell
28,412
-56
-0.2% -$8.88K 3.6% 18
2023
Q3
$4.45M Buy
28,468
+1,560
+6% +$258K 3.54% 18
2023
Q2
$4.41M Buy
26,908
+232
+0.9% +$33.9K 3.48% 17
2023
Q1
$4.12M Buy
26,676
+5,150
+24% +$819K 3.68% 16
2022
Q4
$2.84M Sell
21,526
-1,906
-8% -$259K 3.08% 18
2022
Q3
$2.51M Buy
23,432
+109
+0.5% +$13.7K 2.83% 20
2022
Q2
$2.44M Buy
23,323
+12,322
+112% +$1.67M 2.65% 20
2022
Q1
$1.64M Buy
+11,001
New +$1.35M 1.45% 21

Other funds holding NUE

McBroom & Associates's NUE Position: Q4 2024 in Review

McBroom & Associates sold out of Nucor (NUE) in Q4 2024, closing a stake of 28,045 shares — an estimated $4.22M sold.

McBroom & Associates first reported a position in NUE in Q1 2022 and held it in 11 quarters. The position peaked at $5.56M in Q1 2024. 1,178 funds tracked by Wall St. Rank hold NUE as of Q4 2024.

  • McBroom & Associates reported no remaining Nucor position as of Q4 2024 after selling out during the quarter.
  • McBroom & Associates sold 28,045 Nucor shares in Q4 2024, an estimated $4.22M.
  • McBroom & Associates first reported a position in Nucor in Q1 2022 and held it in 11 quarters.
  • McBroom & Associates's Nucor position peaked at $5.56M in Q1 2024.
  • 1,178 funds tracked by Wall St. Rank held Nucor as of Q4 2024.

Based on McBroom & Associates's 13F filing for Q4 2024, filed 29 Jan 2025.